Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GLAXO.NS Gross Margin

The Gross Margin of GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) is 57.81%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

GLAXO.NS Gross Margin - Historical Value
Date Value
2024-03-31 57.81%
2023-03-31 57.12%
2022-03-31 54.79%
2021-03-31 53.24%
2020-03-31 55.50%
2019-03-31 52.66%
2018-03-31 52.18%
2017-03-31 46.42%
2016-03-31 48.85%
2015-03-31 53.13%
GLAXO.NS Gross Margin - Peers Comparison